Home
>
Chemical Reagents>Impurities>Organic Building Blocks>
>
4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid
For research use only. Not for therapeutic Use.
4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl butyric acid(CAT: C000041) is an open-chain impurity associated with lenalidomide, a medication used in the treatment of multiple myeloma and myelodysplastic syndromes. In pharmaceutical chemistry, understanding and characterizing impurities like this compound is crucial for ensuring the quality and safety of the final drug product. Impurities can arise during the synthesis and manufacturing processes, and their identification and control are essential to meet regulatory standards and ensure the efficacy and safety of lenalidomide in clinical use
Catalog Number | C000041 |
CAS Number | 2197414-57-4 |
Synonyms | 2-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)pentanedioic acid |
Molecular Formula | C₁₃H₁₄N₃O₄ |
Purity | ≥95% |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | Off-White to Pale Beige Solid |
Storage | 4°C, Inert atmosphere |
Reference | Bartlett, J.B., et al.: Nature Rev., 4, 314 (2004), Mitsiades, C.S., et al.: Curr. Opin. Invest. Drugs, 5, 635 (2004), List, A., et al.: N. Engl. J. Med., 352, 549 (2005), |